|
1 |
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts
Riedel, Fabian. - Heidelberg : Universitätsbibliothek Heidelberg, 2025
|
|
|
|
2 |
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Michel, Laura L.. - Augsburg : Universität Augsburg, 2025
|
|
|
3 |
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 85, 2025, Nr. 04: 378-394
|
|
|
|
4 |
Successful bilateral ureteral occlusion using liquid embolization for anastomotic insufficiency and insufficiency of an ileal conduit
Enthalten in RöFo 08.09.2025
|
|
|
|
5 |
Awareness and intention-to-use of digital health applications, artificial intelligence and blockchain technology in breast cancer care
Griewing, Sebastian. - Marburg : Philipps-Universität Marburg, 2024
|
|
|
|
6 |
Comparing the HER2 status of the primary tumor to that of disseminated tumor cells in early breast cancer
Volmer, Lea L.. - Freiburg : Universität, 2024
|
|
|
|
7 |
Implementation and evaluation of a breast cancer disease model using real-world claims data in Germany from 2010 to 2020
Dannehl, Dominik. - Freiburg : Universität, 2024
|
|
|
|
8 |
Prenatal paternal depression, anxiety, and somatic symptom burden in different risk samples: an explorative study
Zacher, Magdalena. - Würzburg : Universität Würzburg, 2024
|
|
|
|
9 |
Current Developments from Silicon Valley – How Artificial Intelligence is Changing Gynecology and Obstetrics
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 12: 1118-1125
|
|
|
|
10 |
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 05: 459-469
|
|
Administration
